Last updated: June 3, 2026
Why stack peptides
Peptides with complementary mechanisms can produce synergistic effects. The classic example is CJC-1295 (GHRH analog, stimulates GH production) + Ipamorelin (GHRP, triggers GH release). They act on different pathways and their combined effect exceeds either alone.
Conversely, stacking two peptides with the same receptor target produces no synergy — only additive side effects. Combining two GLP-1 agonists (semaglutide + tirzepatide) is irrational.
The most-studied stacks
CJC-1295 + Ipamorelin (growth hormone)
GHRH + GHRP combination for amplified pulsatile GH release. Most common stack in growth hormone research.
BPC-157 + TB-500 (tissue repair)
BPC-157 promotes angiogenesis; TB-500 promotes cell migration. Theoretical synergy for tissue repair. No published controlled trial directly testing the combination.
Tesamorelin + Ipamorelin
Long-acting GHRH (Tesamorelin, ~26 minute half-life) + short-acting GHRP (Ipamorelin). Provides sustained pituitary stimulation with discrete GH pulses.
Sermorelin + GHRP-2
Older GHRH+GHRP combination. Less clean than CJC-1295/Ipamorelin due to GHRP-2’s cortisol elevation.
Epitalon + Thymalin + others (longevity)
Khavinson-style bioregulator combinations. Different tissue targets so theoretically non-interacting.
Stacks that don’t make sense
- Two GLP-1 agonists (semaglutide + tirzepatide) — same receptor
- Two GHRPs without a GHRH (Ipamorelin + GHRP-6) — same receptor, no synergy
- Multiple anxiolytic peptides (Selank + Semax) — may have additive sedation
Dosing considerations when stacking
When combining peptides:
- Start with lower doses than monotherapy to assess tolerability
- Stagger introduction by 1-2 weeks rather than starting both simultaneously
- Monitor relevant labs (IGF-1, fasting insulin, HbA1c) more frequently
- Cycle off both peptides together rather than continuous use
What’s the safest peptide stack?<br />
CJC-1295 (no DAC) + Ipamorelin has the cleanest safety profile in the GH category. BPC-157 + TB-500 has favorable rodent safety data but limited human data.
Can you stack GLP-1s?<br />
No — combining semaglutide and tirzepatide produces additive side effects without additive benefit. The receptor is saturated.
Should peptides be cycled?<br />
Yes — most protocols cycle 8-12 weeks on followed by 4 weeks off to allow endogenous regulation to reset. Continuous long-term use is not well-studied.
Do peptide stacks WADA-test?<br />
Most stacked peptides are individually WADA-banned. Detection methods are improving; competitive athletes should not use any GH-stimulating, IGF-1, or recovery peptide.
Related guides: CJC-1295 + Ipamorelin stack · How to measure peptide doses · Peptide cycling explained